Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, January 29, 2015
Technology Networks
 
Register | Sign in
Home Page
  About Us

Technology Networks

Established since 2000, Technology Networks is a major online publisher focused on delivering relevant information to the life sciences and drug discovery communities.

In addition to this, our main website, we also produce LabTube - the main scientific video site and ePosters, The Online Journal of Scientific Posters.

Our Communities
Agrigenomics Biologics and Bioprocessing
Biomolecular Screening Cell Culture Chemical Process Scale Up
Chromotography Crystallography Environmental Analysis
Food and Beverage Forensic Science & Clinical Toxicology Gene Silencing
Genomics Genotyping and Gene Expression Immunology
Informatics Lab-on-a-Chip
LIMs and ELNs Market Reports Mass Spectrometry
Medicinal Chemistry Metabolomics and Lipidomics Molecular and Clinical Diagnostics
Next Gen Sequencing PharmaOutsourcing Proteomics
qPCR Spectroscopy Stem Cells, Cellular Therapy & Biobanking

Scientific News
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Early Blood Glucose Control Lengthens Life in People with Type 1 Diabetes
Reductions in diabetes complications resulting from tight glucose control translate into longer lifespans.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Stem Cell Transplants May Halt Progression of Multiple Sclerosis
NIH-funded study yields encouraging early results.
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Parkinson's Vaccine: EU-Team Launches Clinical Trial
Vaccine candidate based on proprietary technology by AFFiRiS AG.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Scroll Up
Scroll Down
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn